{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T19:34:10Z","timestamp":1789932850983,"version":"4.0.1"},"reference-count":62,"publisher":"American Society of Hematology","issue":"15","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,8,14]]},"abstract":"<jats:title>Key Points<\/jats:title>\n                  <jats:p>SC411 increases DHA in blood cell membranes and reduces home-managed SCD pain crisis and analgesic and opioid use at home to treat SCD pain. The rate of sickle cell crisis was 53% lower for the pooled active groups vs placebo.<\/jats:p>","DOI":"10.1182\/bloodadvances.2018021444","type":"journal-article","created":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T16:18:50Z","timestamp":1536941930000},"page":"1969-1979","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":36,"title":["Double-blind, randomized, multicenter phase 2 study of SC411 in children with sickle cell disease (SCOT trial)"],"prefix":"10.1182","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2122-6813","authenticated-orcid":false,"given":"Ahmed A.","family":"Daak","sequence":"first","affiliation":[{"name":"Sancilio Pharmaceuticals Company, Inc., Riviera Beach, FL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlton D.","family":"Dampier","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beng","family":"Fuh","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, East Carolina University, Greenville, NC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Kanter","sequence":"additional","affiliation":[{"name":"Division Hematology-Oncology, Department of Pediatrics, Medical University of South Carolina, Charleston, SC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ofelia A.","family":"Alvarez","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Pediatrics, University of Miami, Miami, FL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Vandy","family":"Black","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology and Oncology, Department of Pediatrics, University of Florida College of Medicine, Gainesville, FL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa A.","family":"McNaull","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology\/Oncology\/BMT, Department of Pediatrics, University of Mississippi Medical Center, Jackson, MS;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael U.","family":"Callaghan","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital of Michigan, Detroit, MI;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"George","sequence":"additional","affiliation":[{"name":"Texas Children\u2019s Hospital, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne","family":"Neumayr","sequence":"additional","affiliation":[{"name":"Benioff Children\u2019s Hospital, University of California, San Francisco, Oakland, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee M.","family":"Hilliard","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology\/Oncology, University of Alabama at Birmingham, Birmingham, AL; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrick","family":"Sancilio","sequence":"additional","affiliation":[{"name":"Sancilio Pharmaceuticals Company, Inc., Riviera Beach, FL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian L.","family":"Rabinowicz","sequence":"additional","affiliation":[{"name":"Sancilio Pharmaceuticals Company, Inc., Riviera Beach, FL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1104-6843","authenticated-orcid":false,"given":"Matthew M.","family":"Heeney","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Pediatrics, Boston Children\u2019s Hospital, Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2018,8,10]]},"reference":[{"issue":"16","key":"2019111617363703000_B1","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJMra1510865","article-title":"Sickle cell disease","volume":"376","author":"Piel","year":"2017","journal-title":"N Engl J Med"},{"issue":"7","key":"2019111617363703000_B2","doi-asserted-by":"crossref","first-page":"e1001484","DOI":"10.1371\/journal.pmed.1001484","article-title":"Global burden of sickle cell anaemia in children under five, 2010-2050: modelling based on demographics, excess mortality, and interventions","volume":"10","author":"Piel","year":"2013","journal-title":"PLoS Med"},{"issue":"4 Suppl","key":"2019111617363703000_B3","doi-asserted-by":"crossref","first-page":"S512","DOI":"10.1016\/j.amepre.2009.12.022","article-title":"Population estimates of sickle cell disease in the U.S","volume":"38","author":"Hassell","year":"2010","journal-title":"Am J Prev Med"},{"issue":"3","key":"2019111617363703000_B4","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1182\/blood-2002-05-1453","article-title":"Effect of a comprehensive clinical care program on disease course in severely ill children with sickle cell anemia in a sub-Saharan African setting","volume":"102","author":"Rahimy","year":"2003","journal-title":"Blood"},{"issue":"4","key":"2019111617363703000_B5","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/00034983.1979.11687263","article-title":"Abnormal haemoglobins in the Sudan savanna of Nigeria. III. Malaria, immunoglobulins and antimalarial antibodies in sickle cell disease","volume":"73","author":"Molineaux","year":"1979","journal-title":"Ann Trop Med Parasitol"},{"issue":"11","key":"2019111617363703000_B6","doi-asserted-by":"crossref","first-page":"e79923","DOI":"10.1371\/journal.pone.0079923","article-title":"Severe painful vaso-occlusive crises and mortality in a contemporary adult sickle cell anemia cohort study","volume":"8","author":"Darbari","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"2019111617363703000_B7","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1172\/JCI10726","article-title":"Sickle cell anemia as an inflammatory disease","volume":"106","author":"Platt","year":"2000","journal-title":"J Clin Invest"},{"issue":"1","key":"2019111617363703000_B8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/10739680802279394","article-title":"Sickle red cell-endothelium interactions","volume":"16","author":"Kaul","year":"2009","journal-title":"Microcirculation"},{"issue":"2","key":"2019111617363703000_B9","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/10739680490278277","article-title":"The not-so-simple process of sickle cell vasoocclusion","volume":"11","author":"Embury","year":"2004","journal-title":"Microcirculation"},{"issue":"2","key":"2019111617363703000_B10","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1182\/blood.V77.2.214.214","article-title":"Beyond hemoglobin polymerization: the red blood cell membrane and sickle disease pathophysiology","volume":"77","author":"Hebbel","year":"1991","journal-title":"Blood"},{"issue":"1","key":"2019111617363703000_B11","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/iub.584","article-title":"Role of oxidative stress in the pathogenesis of sickle cell disease","volume":"64","author":"Chirico","year":"2012","journal-title":"IUBMB Life"},{"issue":"2","key":"2019111617363703000_B12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/00062752-200203000-00003","article-title":"Sickle cell vaso-occlusion: multistep and multicellular paradigm","volume":"9","author":"Frenette","year":"2002","journal-title":"Curr Opin Hematol"},{"issue":"9757","key":"2019111617363703000_B13","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(10)61029-X","article-title":"Sickle-cell disease","volume":"376","author":"Rees","year":"2010","journal-title":"Lancet"},{"issue":"7","key":"2019111617363703000_B14","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJMoa1512021","article-title":"A multinational trial of prasugrel for sickle cell vaso-occlusive events","volume":"374","author":"Heeney","year":"2016","journal-title":"N Engl J Med"},{"key":"2019111617363703000_B15","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1182\/asheducation-2017.1.440","article-title":"Evolving treatment paradigms in sickle cell disease","volume":"2017","author":"Jagadeeswaran","year":"2017","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"1","key":"2019111617363703000_B16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3945\/ajcn.112.036319","article-title":"Effect of omega-3 (n-3) fatty acid supplementation in patients with sickle cell anemia: randomized, double-blind, placebo-controlled trial","volume":"97","author":"Daak","year":"2013","journal-title":"Am J Clin Nutr"},{"key":"2019111617363703000_B17","first-page":"236374","article-title":"Addition of multimodal therapy to standard management of steady state sickle cell disease","volume-title":"ISRN Hematol","author":"Okpala","year":"2013"},{"issue":"6","key":"2019111617363703000_B18","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1055\/s-0037-1615948","article-title":"Reduction of pain episodes and prothrombotic activity in sickle cell disease by dietary n-3 fatty acids","volume":"85","author":"Tomer","year":"2001","journal-title":"Thromb Haemost"},{"issue":"5","key":"2019111617363703000_B19","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.plefa.2013.09.006","article-title":"Docosahexaenoic and eicosapentaenoic acid supplementation does not exacerbate oxidative stress or intravascular haemolysis in homozygous sickle cell patients","volume":"89","author":"Daak","year":"2013","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"1","key":"2019111617363703000_B20","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bcmd.2015.03.014","article-title":"Omega 3 (n-3) fatty acids down-regulate nuclear factor-kappa B (NF-\u03baB) gene and blood cell adhesion molecule expression in patients with homozygous sickle cell disease","volume":"55","author":"Daak","year":"2015","journal-title":"Blood Cells Mol Dis"},{"issue":"7","key":"2019111617363703000_B21","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1600-0463.2011.02751.x","article-title":"Pilot study of omega-3 fatty acid supplements in sickle cell disease","volume":"119","author":"Okpala","year":"2011","journal-title":"APMIS"},{"issue":"1","key":"2019111617363703000_B22","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12878-017-0089-5","article-title":"Coagulation profile of Sudanese children with homozygous sickle cell disease and the effect of treatment with omega-3 fatty acid on the coagulation parameters","volume":"17","author":"Awoda","year":"2017","journal-title":"BMC Hematol"},{"issue":"1","key":"2019111617363703000_B23","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1079\/NRR200497","article-title":"The impact of long-chain n-3 polyunsaturated fatty acids on human health","volume":"18","author":"Ruxton","year":"2005","journal-title":"Nutr Res Rev"},{"issue":"3","key":"2019111617363703000_B24","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-2125.2012.04374.x","article-title":"Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology?","volume":"75","author":"Calder","year":"2013","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"2019111617363703000_B25","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.immuni.2014.02.009","article-title":"Proresolving lipid mediators and mechanisms in the resolution of acute inflammation","volume":"40","author":"Buckley","year":"2014","journal-title":"Immunity"},{"issue":"11","key":"2019111617363703000_B26","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.tins.2011.08.005","article-title":"Emerging roles of resolvins in the resolution of inflammation and pain","volume":"34","author":"Ji","year":"2011","journal-title":"Trends Neurosci"},{"issue":"3","key":"2019111617363703000_B27","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10238-014-0293-6","article-title":"LC-MS\/MS analysis of plasma polyunsaturated fatty acids in patients with homozygous sickle cell disease","volume":"15","author":"Aslan","year":"2015","journal-title":"Clin Exp Med"},{"key":"2019111617363703000_B28","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/718014","article-title":"Hydroxyurea therapy mobilises arachidonic Acid from inner cell membrane aminophospholipids in patients with homozygous sickle cell disease","author":"Daak","year":"2011"},{"issue":"9","key":"2019111617363703000_B29","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s00277-005-1023-7","article-title":"Blood mononuclear cells and platelets have abnormal fatty acid composition in homozygous sickle cell disease","volume":"84","author":"Ren","year":"2005","journal-title":"Ann Hematol"},{"issue":"2","key":"2019111617363703000_B30","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.bcmd.2014.11.004","article-title":"Dietary supplementation with docosahexanoic acid (DHA) increases red blood cell membrane flexibility in mice with sickle cell disease","volume":"54","author":"Wandersee","year":"2015","journal-title":"Blood Cells Mol Dis"},{"issue":"7","key":"2019111617363703000_B31","doi-asserted-by":"crossref","first-page":"870","DOI":"10.3324\/haematol.2015.124586","article-title":"Dietary \u03c9-3 fatty acids protect against vasculopathy in a transgenic mouse model of sickle cell disease","volume":"100","author":"Kalish","year":"2015","journal-title":"Haematologica"},{"issue":"2","key":"2019111617363703000_B32","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jacl.2017.01.017","article-title":"Minimal food effect for eicosapentaenoic acid and docosahexaenoic acid bioavailability from omega-3-acid ethyl esters with an Advanced Lipid TechnologiesTM (ALT\u00ae)-based formulation","volume":"11","author":"Lopez-Toledano","year":"2017","journal-title":"J Clin Lipidol"},{"issue":"3","key":"2019111617363703000_B33","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.clinthera.2017.01.020","article-title":"A novel \u03c9-3 acid ethyl ester formulation incorporating Advanced Lipid TechnologiesTM (ALT\u00ae) improves docosahexaenoic acid and eicosapentaenoic acid bioavailability compared with Lovaza\u00ae","volume":"39","author":"Lopez-Toledano","year":"2017","journal-title":"Clin Ther"},{"issue":"1","key":"2019111617363703000_B34","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/ajh.21550","article-title":"Definitions of the phenotypic manifestations of sickle cell disease","volume":"85","author":"Ballas","year":"2010","journal-title":"Am J Hematol"},{"issue":"6 Suppl","key":"2019111617363703000_B35","doi-asserted-by":"crossref","first-page":"1467S","DOI":"10.1093\/ajcn\/83.6.1467S","article-title":"Distribution, interconversion, and dose response of n-3 fatty acids in humans","volume":"83","author":"Arterburn","year":"2006","journal-title":"Am J Clin Nutr"},{"issue":"4","key":"2019111617363703000_B36","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.plefa.2012.12.004","article-title":"Erythrocyte omega-3 fatty acids increase and linoleic acid decreases with age: observations from 160,000 patients","volume":"88","author":"Harris","year":"2013","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"2","key":"2019111617363703000_B37","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1001\/jama.1989.03420020120042","article-title":"Herrick\u2019s 1910 case report of sickle cell anemia. The rest of the story","volume":"261","author":"Savitt","year":"1989","journal-title":"JAMA"},{"issue":"9778","key":"2019111617363703000_B38","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/S0140-6736(11)60355-3","article-title":"Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG)","volume":"377","author":"Wang","year":"2011","journal-title":"Lancet"},{"issue":"1","key":"2019111617363703000_B39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/187152909787581354","article-title":"Promising therapies in sickle cell disease","volume":"9","author":"Raghupathy","year":"2009","journal-title":"Cardiovasc Hematol Disord Drug Targets"},{"key":"2019111617363703000_B40","year":"2018"},{"issue":"5","key":"2019111617363703000_B41","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jacc.2009.06.065","article-title":"Trial and error. How to avoid commonly encountered limitations of published clinical trials","volume":"55","author":"Kaul","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2019111617363703000_B42","doi-asserted-by":"crossref","first-page":"4","DOI":"10.12688\/f1000research.6615.1","article-title":"Biomarkers and recent advances in the management and therapy of sickle cell disease","volume":"4","author":"Telen","year":"2015","journal-title":"F1000 Res"},{"issue":"1","key":"2019111617363703000_B43","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/bjh.12336","article-title":"Interplay between coagulation and vascular inflammation in sickle cell disease","volume":"162","author":"Sparkenbaugh","year":"2013","journal-title":"Br J Haematol"},{"issue":"31","key":"2019111617363703000_B44","doi-asserted-by":"crossref","first-page":"10858","DOI":"10.1073\/pnas.0502903102","article-title":"Docosahexaenoic acid: a positive modulator of Akt signaling in neuronal survival","volume":"102","author":"Akbar","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2019111617363703000_B45","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0005-2736(99)00032-2","article-title":"Docosahexaenoic acid (DHA) alters the phospholipid molecular species composition of membranous vesicles exfoliated from the surface of a murine leukemia cell line","volume":"1418","author":"Williams","year":"1999","journal-title":"Biochim Biophys Acta"},{"issue":"1 1 Pt B","key":"2019111617363703000_B46","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.bbamem.2014.04.020","article-title":"How polyunsaturated fatty acids modify molecular organization in membranes: insight from NMR studies of model systems","volume":"1848","author":"Shaikh","year":"2015","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"2019111617363703000_B47","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/j.bbamem.2013.12.021","article-title":"The effect of natural and synthetic fatty acids on membrane structure, microdomain organization, cellular functions and human health","volume":"1838","author":"Ibarguren","year":"2014","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"2019111617363703000_B48","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0005-2736(88)90250-7","article-title":"Studies on sickled erythrocytes provide evidence that the asymmetric distribution of phosphatidylserine in the red cell membrane is maintained by both ATP-dependent translocation and interaction with membrane skeletal proteins","volume":"937","author":"Middelkoop","year":"1988","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"2019111617363703000_B49","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1182\/blood.V87.3.1179.bloodjournal8731179","article-title":"Detection of altered membrane phospholipid asymmetry in subpopulations of human red blood cells using fluorescently labeled annexin V","volume":"87","author":"Kuypers","year":"1996","journal-title":"Blood"},{"issue":"3","key":"2019111617363703000_B50","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1046\/j.1365-2141.2002.03711.x","article-title":"Relationship between hypercoagulable state and erythrocyte phosphatidylserine exposure in splenectomized haemoglobin E\/beta-thalassaemic patients","volume":"118","author":"Atichartakarn","year":"2002","journal-title":"Br J Haematol"},{"issue":"6","key":"2019111617363703000_B51","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1172\/JCI111913","article-title":"Increased adherence of sickled and phosphatidylserine-enriched human erythrocytes to cultured human peripheral blood monocytes","volume":"75","author":"Schwartz","year":"1985","journal-title":"J Clin Invest"},{"issue":"4","key":"2019111617363703000_B52","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1182\/blood.V95.4.1293.004k42_1293_1300","article-title":"Adherence of phosphatidylserine-exposing erythrocytes to endothelial matrix thrombospondin","volume":"95","author":"Manodori","year":"2000","journal-title":"Blood"},{"issue":"5","key":"2019111617363703000_B53","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1182\/blood.V99.5.1564","article-title":"Role of erythrocyte phosphatidylserine in sickle red cell-endothelial adhesion","volume":"99","author":"Setty","year":"2002","journal-title":"Blood"},{"issue":"12","key":"2019111617363703000_B54","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/sj.cdd.4400946","article-title":"Programmed cell death in mature erythrocytes: a model for investigating death effector pathways operating in the absence of mitochondria","volume":"8","author":"Bratosin","year":"2001","journal-title":"Cell Death Differ"},{"issue":"5","key":"2019111617363703000_B55","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000086406","article-title":"Mechanisms of suicidal erythrocyte death","volume":"15","author":"Lang","year":"2005","journal-title":"Cell Physiol Biochem"},{"issue":"2","key":"2019111617363703000_B56","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1074\/jbc.M505790200","article-title":"Hydrolysis of phosphatidylserine-exposing red blood cells by secretory phospholipase A2 generates lysophosphatidic acid and results in vascular dysfunction","volume":"281","author":"Neidlinger","year":"2006","journal-title":"J Biol Chem"},{"issue":"6","key":"2019111617363703000_B57","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0092-8674(95)90295-3","article-title":"Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells","volume":"80","author":"Fourcade","year":"1995","journal-title":"Cell"},{"issue":"6","key":"2019111617363703000_B58","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1073\/pnas.95.6.3077","article-title":"Phosphatidylserine exposure and red cell viability in red cell aging and in hemolytic anemia","volume":"95","author":"Boas","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"2019111617363703000_B59","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1128\/AEM.02256-07","article-title":"Significance of antioxidative functions of eicosapentaenoic and docosahexaenoic acids in marine microorganisms","volume":"74","author":"Okuyama","year":"2008","journal-title":"Appl Environ Microbiol"},{"issue":"12","key":"2019111617363703000_B60","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1016\/S0022-2275(20)30036-5","article-title":"Abnormal phospholipid molecular species of erythrocytes in sickle cell anemia","volume":"38","author":"Connor","year":"1997","journal-title":"J Lipid Res"},{"issue":"12","key":"2019111617363703000_B61","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1007\/s11745-999-0481-6","article-title":"Effects of eicosapentaenoic acid and docosahexaenoic acid on plasma membrane fluidity of aortic endothelial cells","volume":"34","author":"Hashimoto","year":"1999","journal-title":"Lipids"},{"issue":"1-2","key":"2019111617363703000_B62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11010-006-0164-x","article-title":"Docosahexaenoic acid but not eicosapentaenoic acid withstands dietary cholesterol-induced decreases in platelet membrane fluidity","volume":"293","author":"Hashimoto","year":"2006","journal-title":"Mol Cell Biochem"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/2\/15\/1969\/881619\/advances021444.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/2\/15\/1969\/881619\/advances021444.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T06:24:46Z","timestamp":1720592686000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/2\/15\/1969\/15990\/Doubleblind-randomized-multicenter-phase-2-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,10]]},"references-count":62,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2018,8,14]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2018021444","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.733827485.793575209","asserted-by":"object"}]},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,10]]}}}